AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Altboum, Z Barry, EM Losonsky, G Galen, JE Levine, MM
Citation: Z. Altboum et al., Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosalvaccine against Shigella and ETEC infection, INFEC IMMUN, 69(5), 2001, pp. 3150-3158

Authors: Tacket, CO Galen, J Sztein, MB Losonsky, G Wyant, TL Nataro, J Wasserman, SS Edelman, R Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C, CLIN IMMUNO, 97(2), 2000, pp. 146-153

Authors: Cooper, PJ Chico, ME Losonsky, G Sandoval, C Espinel, I Sridhara, R Aguilar, M Guevara, A Guderian, RH Levine, MM Griffin, GE Nutman, TB
Citation: Pj. Cooper et al., Albendazole treatment of children with ascariasis enhances the vibriocidalantibody response to the live attenuated oral cholera vaccine CVD 103-HgR, J INFEC DIS, 182(4), 2000, pp. 1199-1206

Authors: Tacket, CO Mason, HS Losonsky, G Estes, MK Levine, MM Arntzen, CJ
Citation: Co. Tacket et al., Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes, J INFEC DIS, 182(1), 2000, pp. 302-305

Authors: Koprowski, H Levine, MM Anderson, RJ Losonsky, G Pizza, M Barry, EM
Citation: H. Koprowski et al., Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli, INFEC IMMUN, 68(9), 2000, pp. 4884-4892

Authors: Tacket, CO Sztein, MB Losonsky, G Abe, A Finlay, BB McNamara, BP Fantry, GT James, SP Nataro, JP Levine, MM Donnenberg, MS
Citation: Co. Tacket et al., Role of EspB in experimental human enteropathogenic Escherichia coli infection, INFEC IMMUN, 68(6), 2000, pp. 3689-3695

Authors: Tacket, CO Sztein, MB Wasserman, SS Losonsky, G Kotloff, KL Wyant, TL Nataro, JP Edelman, R Perry, J Bedford, P Brown, D Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers, INFEC IMMUN, 68(3), 2000, pp. 1196-1201

Authors: Tacket, CO Losonsky, G Livio, S Edelman, R Crabb, J Freedman, D
Citation: Co. Tacket et al., Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milkproduct against enterotoxigenic Escherichia coli challenge administered during a standard meal, J INFEC DIS, 180(6), 1999, pp. 2056-2059

Authors: Tacket, CO Cohen, MB Wasserman, SS Losonsky, G Livio, S Kotloff, K Edelman, R Kaper, JB Cryz, SJ Giannella, RA Schiff, G Levine, MM
Citation: Co. Tacket et al., Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba threemonths after vaccination, INFEC IMMUN, 67(12), 1999, pp. 6341-6345

Authors: Michetti, P Kreiss, C Kotloff, KL Porta, N Blanco, JL Bachmann, D Herranz, M Saldinger, PF Corthesy-Theulaz, I Losonsky, G Nichols, R Simon, J Stolte, M Ackerman, S Monath, TP Blum, AL
Citation: P. Michetti et al., Oral immunization with urease and Escherichia coli heat-labile enterotoxinis safe and immunogenic in Helicobacter pylori-infected adults, GASTROENTY, 116(4), 1999, pp. 804-812
Risultati: 1-10 |